Drug Database
Back to search

Ireland· IE-PA-PA23163/004/001

Abendur 2.5 mg tablets

A bendroflumethiazide product containing bendroflumethiazide, registered in Ireland by Ascot Laboratories (Ireland) Limited. The same ATC class is registered in 2 of our 19 countries.

ATC C03AA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedAbendur 2.5 mg tabletsATCC03AA01REGISTER NO.IE-PA-PA23163/004/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bendroflumethiazideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bendroflumethiazide is registered in 2 of 19 countries.

Countries holding a registration under ATC C03AA01 (bendroflumethiazide), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
Search bendroflumethiazide products by name

Bendroflumethiazide · ATC C03AA01

2 / 19 countries

  • Ireland
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Bendroflumethiazide
Manufacturer
Ascot Laboratories (Ireland) Limited
Country
Ireland (IE)
ATC code
C03AA01
ATC class
Bendroflumethiazide
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23163/004/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

220 interactions on record for bendroflumethiazide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bendroflumethiazide against other medicinesHow interaction checks work

Bendroflumethiazide · interactions on record

220 records

  • 4 severe
  • 199 moderate
  • 17 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Aminolevulinic acidL01XD04severe
  • Arsenic trioxideL01XX27severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bendroflumethiazide in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bendroflumethiazide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Bendroflumethiazide, Bendroflumethiazide Bristol Laboratories
  • Malta · Bendroflumethiazide, Bendroflumethiazide Brillpharma (Ireland)
  • Sweden · Bendozid, Bendroflumetiazid Alternova

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0d652aa4-79cd-47e4-bbc3-63f43c4be9c0
GET /v1/drugs/0d652aa4-79cd-47e4-bbc3-63f43c4be9c0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "C03AA01"
  ],
  "strength": null,
  "pa_number": "PA23163/004/001",
  "substances": [
    "Bendroflumethiazide"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "16/01/2026",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about bendroflumethiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console